You are here

Eli Lilly

Eli Lilly hit with DOJ subpoena over New Jersey factory making COVID-19 drug

Fierce Pharma

Thu, 05/27/21 - 11:03 am

drug manufacturing

monoclonal antibodies

FDA authorizes Vir-GSK antibody as variants threaten Eli Lilly mAb

Endpoints

Wed, 05/26/21 - 11:42 pm

Vir Biotechnology

monoclonal antibodies

Eli Lilly's mirikizumab improves fatigue in patients with Crohn's disease in Phase 2 trial

Seeking Alpha

Wed, 05/26/21 - 11:34 pm

clinical trials

Crohn’s disease

Lilly leads the big pharma pack on pipeline value

EP Vantage

Tue, 05/25/21 - 11:04 am

Alzheimer's disease

US pauses distribution of Lilly mAb combo to Massachusetts due to Covid-19 variant

Endpoints

Mon, 05/24/21 - 10:57 am

monoclonal antibodies

COVID-19 variants

Precision Medicine Study Points to Promising New Approach in Alzheimer's

BioSpace

Fri, 05/21/21 - 10:53 am

Alzheimer's disease

precision medicine

Eli Lilly sues HHS to halt any 340B-related monetary penalties

Endpoints

Fri, 05/21/21 - 10:50 am

Eli Lilly wraps up fifth and final tirzepatide PhIII trial, claiming a win over Sanofi's Lantus. The FDA awaits

Endpoints

Thu, 05/20/21 - 11:11 am

clinical trials

FDA review of Lilly/Innovent’s sintilimab paves way for cut-price immunotherapy option

Pharmaforum

Wed, 05/19/21 - 10:26 am

Feds stop sending Eli Lilly’s COVID-19 cocktail to Illinois on concerns of P.1 variant

Fierce Pharma

Thu, 05/13/21 - 11:56 pm

Lilly enlists a long-incubating RNA upstart in new $1.25B partnership

Endpoints

Tue, 05/11/21 - 11:06 am

MiNA Therapeutic

Biden's Budget May Boost These 3 Biotechs

Motley Fool

Mon, 05/10/21 - 09:31 pm

Alzheimer's disease

Denali Therapeutics

Cassava Sciences

Eli Lilly taps 3 Indian drugmakers to bolster supply of COVID-19 drug baricitinib

Fierce Pharma

Mon, 05/10/21 - 09:25 pm

drug manufacturing

An employee complaint at Eli Lilly's Branchburg plant alleges altered quality control docs amid FDA probe — report

Endpoints

Wed, 05/5/21 - 11:06 am

drug manufacturing

Lilly takes variant-busting COVID-19 antibody into the clinic

Fierce Biotech

Tue, 05/4/21 - 10:44 am

Crowded psoriasis market cuts Lilly’s mirikizumab ambitions

Pharmaforum

Wed, 04/28/21 - 10:24 am

Lilly, citing FDA feedback, won't seek speedy approval of Alzheimer's drug

BioPharma Dive

Tue, 04/27/21 - 11:25 pm

Alzheimer's disease

Eli Lilly Stock Crumbles As Covid Antibodies Hammer Sales, 2021 Outlook

Investors Business Daily

Tue, 04/27/21 - 10:51 am

Lilly scraps IL-23 psoriasis program despite phase 3 success, focuses on IBD race against AbbVie, J&J

Fierce Biotech

Tue, 04/27/21 - 10:50 am

The retreat of corporate venture funding?

EP Vantage

Fri, 04/23/21 - 11:02 am

venture funding

venture capital

Boehringer Ingelheim

Bristol Myers Squibb

Pages